Background/Aim: Both peroxisome proliferator-activated receptor (PPAR) δ and Ski are reported to be involved in skin wound repair. However, their link is unclear. Our aim is to investigate the interaction of PPARδ and Ski and this interaction-associated effect in wound healing. Methods: Effect of PPARδ activation on Ski expression was detected in rat skin fibroblasts by real-time PCR and western blot. Luciferase assay, electrophoretic mobility shift assay (EMSA) and chromatin immunoprecipitation (ChIP) assay were performed to identify the binding site of PPARδ in the promoter region of rat Ski gene. And the functional activity of PPARδ regulation to Ski was detected in fibroblast proliferation and rat skin wound healing model. Results: PPARδ agonist GW501516 upregulated Ski expression in a dose-dependent manner. Direct repeat-1 (DR1) response element locating at -865~-853 in Ski promoter region was identified to mediate PPARδ binding to Ski and associated induction of Ski. Furthermore, PPARδ upregulated Ski to promote fibroblasts proliferation and rat skin wound repair, which could be largely blocked by pre-treated with Ski RNA interference. Conclusion: This study demonstrates that Ski is a novel target gene for PPARδ and upregulation of Ski to promote fibroblast proliferation is implicated in the PPARδ-mediated wound healing.
Upregulation of Ski in Fibroblast is

Introduction
Acting as a protective shield of body, Skin is subjected to constant aggression and insults that may result in the loss of its integrity and function. Following skin injury, the course of wound healing will be priminged, which includes an overlapping pattern of events such as inflammation, re-epithelialization, generation of granulation tissue and matrix and tissue remodeling [1] . These events are temporally and spatially regulated by a variety of growth factors and cytokines that orchestrate the manifold cellular activities [2] .
Ski, a homologue of the pro-oncogenic v-Ski protein, is highly conserved across various species and widely distributed in different tissues [3] [4] [5] . As a versatile transcriptional regulator, it modulates multiple gene expression and is involved in many physiological and pathological processes [6] [7] [8] [9] . However, the transcriptional or translational modulation of Ski gene in these conditions is not clear. Our recent study has demonstrated that Ski is a new tissue repair-related gene, which is mainly expressed in fibroblasts and modulates wound healing and scar formation by regulating TGF-β-dependent or -independent pathway [10] [11] [12] . Accordingly, it is essential to investigate the endogenous or exogenous factors to regulate Ski expression or function, which has the potential to provide a novel strategy to accelerate wound healing via modulating Ski-mediated signaling and effects.
Nuclear receptors are a class of proteins found within cells that are responsible for sensing steroid and thyroid hormones and certain other molecules. In response, these receptors regulate the expression of specific genes, thereby controlling the development, homeostasis, and metabolism of the organism [13] [14] [15] . The nuclear receptor PPARδ is one identified isoform of peroxisome proliferator-activated receptors (PPARs) [16, 17] . As well as the other two isoforms PPARα and PPARγ, it regulate gene expression by forming heterodimers with the retinoid X receptor (RXR) via specific recognition sequences termed PPAR response elements (PPRE), which are located in the target genes [18] [19] [20] . Recently, multiple evidence have shown that PPARδ has the ability to promote wound healing [21] [22] [23] [24] . Although multiple factors participate in the execution of PPARδ action, its effector genes that it regulates in wound healing remains largely unexplored.
In an attempt to elucidate these issues, we focus on identifying the relationship of Ski and PPARδ in fibroblasts. We report that Ski is a novel target gene for PPARδ. By binding to a functional PPRE localized in the Ski promoter, activation of PPARδ upregulates the expressions of Ski mRNA and protein. And this upregulation is implicated in the effect of PPARδ on promoting fibroblast proliferation and associated skin wound healing in rats.
Materials and Methods
Animals and reagents
Specific pathogen-free adult male and female Wistar rats (180-220 g) were purchased from the Animal Centre, Research Institute of Surgery and Daping Hospital, TMMU, Chongqing, China (Certificate No. scxk (Yu) 2002-0002, grade II). pSuper-c-Ski-RNAi was made previously [11] , which has been confirmed to successfully knockdown Ski expression both in rat fibroblasts and wound tissues in our recent study [10, 11] . Antibodies specific to Ski (sc-9140), PPARδ (sc-7197), β-actin (sc-1616), PPARδ agonist GW501516 (sc-202642) and antagonist GSK0660 (sc-203985) were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA).
Primary fibroblasts culture and treatments
Primary fibroblasts were obtained from back skin of 4-6-week-old Wistar rats. Fibroblast culture was established as described previously [11, 25] . Briefly, fibroblasts were incubated at 5% CO 2 in a humidified 37°C incubator, cultured with Dulbecco's minimum essential medium (DMEM) supplemented with 10% heat-inactivated fetal bovine serum (FBS) three times a week. When cells reached confluence, they were passaged by trypsinization, resuspended and re-plated. Fibroblasts at passage 3-8 were used. These fibroblasts were treated with DMSO or various concentrations of GW501516 (25, 50 and 100 nmol/L) for 
Model of wound healing and treatments
A model for wound healing in rats was used as previously described [26] . Two 2 cm diameter, fullthickness circular skin flaps were cut from the buttocks. One wound was treated with medicines, while the other wound was used as an internal control. Injured rats were randomly divided into two groups: (1) one wound (left) was injected with 100 µg GW501516, and the internal control side (right) was injected with vechical (DMSO); (2) the left wound was pre-injected 100 µg pSuper-c-Ski-RNAi (which has been reported to successfully knock down of Ski in vivo in our recent study [10] and 6 hours later followed with 100 µg GW501516 treatment, while the right wound was injected with DMSO. These medicines were administrated to animals immediately after wounding firstly and then injected weekly. On day 0, 6, 12 and 18 postwounding, the expression of Ski mRNA and protein, wound closure and histopathological analysis were determined and observed. At least six animals were used in each detection or assay.
Real-time PCR and western blot assays
Total RNA was isolated from all samples using TRIzol (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's instructions, and total protein was extracted using M-PERTM protein extraction reagent (Pierce, Rockford, IL, USA). Quantitative polymerase chain reaction (qPCR) amplification was performed in triplicate, using the SYBR Green PCR reagent system. Primers for Ski: sense, 5'-TCA ACT CGG TGT GCG ATG-3', and antisense,5'-CGT CCG TCT TGG TGA TGA G-3';and for glyceraldehyde-3-Phosphatedehydro-genase (GAPDH): sense, 5'-AGG TTG TCT CCT GCG ACT T-CA-3', and antisense, 5'-TGG TCC AGG GTT TCT TAC TCC-3'. Real-time PCR was carried out as follows: initial denaturation for 5 min at 94°C and 40 cycles of PCR consisting of 15 s at 94°C, 15 s at 59°C and 20 s at 72°C. Quantifications were always normalized using endogenous control GAPDH.
For western blot assay, whole-cell lysates of cultured fibroblasts or wound tissues of rat wound healing model were collected with M-PERTM protein extraction reagent (Pierce) containing protease inhibitormixture (Calbiochem) to detect Ski expression. Equal amounts of protein were separated by SDS/ PAGE (10% gels) and transferred on to an Immobilon-P PVDF membrane (Millipore). The expression of β-actin in each sample was also detected to show equal protein loading.
Plasmid construction and site-directed mutagenesis
Rat Ski promoter region containing fragment (−2277~-19) was amplified by PCR with the oligonucleotides 5'-CGG GGT ACC GAT TTG GCT GTC CCT TC-3' (forward primer) and 5'-CCG CTC GAG TCC TTT GAC CCT CTA CC -3' (reverse primer) using fibroblasts-derived genomic DNA as template. The fragment was cloned into pGL3-basic vector after digestion with Kpn I and Xhol, and the resulting plasmid was named as pGL3-Ski. The deletion mutants of this luciferase reporter vector were amplified and these forward primers are as followed: (1) (7) pGL3-Ski -331~-19 : 5'-CGG GGT ACC AGA CCC TTG TGG AAG CCC TG-3'. Their reverse primers are similar to pGL3-Ski as described above. In addition, a nucleotide substitution was introduced into the DR1 site (-865~-853) in the Ski promoter using the QuikChange site-directed mutagenesis kit (Stratagene, CA). PCR amplification of the wild-type rat pGL3-Ski luciferase reporter plasmid was performed using site-directed mutation primers: 5'-GGG ATA GTC TTA AGG CGA GTA GAC ATG TAG AAG GTA CAG GC-3' (forward) and 5'-GCC TGT ACC TTC TAC ATG TCT ACT CGC CTT AAG ACTA TCC C-3' (reverse).
Luciferase assay
Fibroblasts, grown to 80-90% confluence in 48-well plates, were transiently transfected using Lipofectamine 2000 with luciferase reporter pGL3-Ski and its mutants respectively. Five hours after transfection, fresh complete medium was added and the cells were incubated for another 4 h. Then the cells were treated with GW501516 (50 nmol/L), or GSK0660 (1 µmol/L) followed by GW501516 (50 nmol/L), or Cell extracts were prepared, and the luciferase and β-galactosidase assays were performed using the corresponding assay system according to the manufacturer's instructions (Promega, USA). Transfection experiments were performed at least 3 times in triplicate. And the luciferase activity was normalized against β-galactosidase activity.
Electrophoretic mobility shift assay (EMSA) EMSA was performed as described previously [27] . In brief, the DNA probe containing a putative PPAR response element (PPRE/DR1,−865~−853) (forward: 5'-CTTAAGGTAAGGGGACATGTA-3', reverse: 5'-TACATGTCCCCTTACCTTAA-G-3') or its mutated consensus sequence (forward: 5'-CTTAAGGCGAGGTAACA TGTA-3', reverse: 5'-TACATACTCCCTTAAAGTAAG-3') was synthesized. It was end-labeled with biotin. The EMSA was performed using the LightShift chemiluminescent EMSA kit (Pierce, Rockford, IL, USA) according to the manufacturer's instructions. Briefly, the labeled probes were incubated with the nuclear extracts from fibroblasts for 20min at 25 °C, and then the reaction samples were electrophoresed on a 6% non-denaturing acrylamide gel in a 0.5× Tris-borate-EDTA buffer. After transferred to nylon membrane, the biotin-labeled probes were detected. For supershift experiments, anti-PPARδ antibody (sc-7197, Santa Cruz, USA) was preincubated for 20 min in binding buffer prior to the addition of the nuclear extracts as described above.
Chromatin Immunoprecipitation (ChIP) Assay
ChIP assays were performed using a ChIP assay kit (Upstate Biotechnology, Lake Placid, NY, USA) according to the manufacture's instructions. Briefly, after treatment with 50 nmol/L GW501516 for 24 h, fibroblasts were cross linked with 1% formaldehyde, and then disrupted in SDS lysis buffer containing the protein inhibitor cocktail. Chromatin was sonicated to shear DNA to an average length between 200 and 1000 bp as verified by agarose gel. Subsequently, chromatin was immunoprecipitated with anti-PPARδ antibody (sc-7197, Santa Cruz, USA), taking rat IgG as negative control. Final DNA extractions were PCR amplified using primer pairs that cover the novel DR1 sequence in the Ski promoter region as follows: forward primer, 5'-TCTGTTTGGCTGGCCTGAGGGA-3'; reverse primer, 5'-AAGATAGATCCCAGACTTTAT-3'.
Proliferation assay of fibroblasts
Proliferation of fibroblasts was determined by Cell Count Kit-8 (CCK-8 Kit, Beyotime Inst Biotech, China) using WST-8(2-(2-methoxy-4-nitrophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium, monosodium salt) dye method in accordance with the manufacturer's instructions and the references [28, 29] . Briefly, rat skin fibroblasts were synchronized with DMEM/0.4% FBS for 24 h and subsequently treated with GW501516 (50 nmol/L) or DMSO. To investigate whether Ski was implicated in the effect of PPARδ activation on fibroblasts proliferation, 200 ng pSuper-Ski-RNAi was transfected into fibroblasts for 6 hours and its effect on Ski protein expression was detected by western blot as previously described, which has been confirmed to efficiently RNAi Ski expression in fibroblasts in our recent study [11] , then followed by GW501516 treatment. And 24 h, 48 h and 72 h after GW501516 or DMSO treatment respectively, the cells were incubated for 4 h at 37°C with WST-8 and the absorbance was finally determined at 450 nm using a microplate reader.
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Results
Treatment with PPARδ agonists leads to upregulation of Ski in rat fibroblast cells
When the primary cultured rat fibroblasts were treated with GW501516, a specific ligand of PPARδ, siginificant increases of Ski mRNA and protein levels were demonstrated in a concentration-dependent manner (Fig. 1A and B) . To confirm this regulation of Ski by GW501516 was medicated by its activity to activate PPARδ, we next investigated the effects of GSK0660, which is an irreversible inhibitor of PPARδ and observed a significant reduction in PPARδ-induced upregulation of Ski (Fig. 1C and D) . These data indicate clearly that Ski expression is regulated in a PPARδ-dependent manner.
PPARδ activation enhances transcriptional activation of ski promoter Upregulation of Ski mRNA by GW501516 suggests that PPARδ activation modulates Ski expression at the transcriptional level. We then hypothesized that activation of PPARδ enhances Ski expression may be due to exert its stimulatory activity on Ski promoter. To test this hypothesis, we constructed a luciferase reporter plasmid (pGL3-Ski) that was driven by rat Ski promoter region (−2277~-19). Following transfected with pGL3-Ski, rat fibroblasts were treated with PPARδ ligand GW501516. As shown in Figure 2 , GW501516 administration significantly enhanced the Ski promoter activity, but the increase in promoter activity was substantially attenuated when the cells were pretreated with PPARδ selective antagonist GSK0660. These results indicate that activation of PPARδ enhances Ski promoter activity. Being exogenous PPARδ and retenoid X receptor (RXR) α were not transfected to the cells, these results also suggest that endogenous PPARδ in fibroblasts is sufficient to elicit this activity.
PPARδ Binds to the PPRE in the Ski Gene Promoter
To search for PPRE that may mediate Ski induction by PPARδ ligand, the rat Ski promoter region (−2277~-19) was subjected to in silico analysis with a Web-based algorithm (NUBIScan) [17] . Combination with analysis of relative references, nine predicted 
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potential PPREs were selected and their sequences and locations were shown in Table  1 . To determine which element is responsible for the directly binding of PPARδ, reporter assays were performed using serially truncated constructs driven by the Ski promoter. The response to PPARδ was almost completely abolished on the deletion of sequences located between -958 and -851, which indicates that the element responsible for PPARδ is located between -958 and -851 bp upstream of the rat Ski gene (Fig. 3A) . As shown in Table 1 and Figure 3B , this region contains a putative DR1 element at positions -865 to -853 of the Ski promoter. To assess whether or not this PPRE mediates transcriptional activation by PPARδ, we introduced mutations into the Ski promoter construct. In the presence of the wild-type Ski-DR1 site, GW501516-mediated PPARδ activation resulted in significant increase in transcriptional activity. However, mutations of the DR1 caused loss of promoter activation by the PPARδ ligand (Fig. 3C) . These results clearly demonstrate that this DR1 site mediates the PPARδ binding and regulation to Ski promoter. To determine whether or not PPARδ binds directly to the Ski-DR1 site, we performed EMSA and ChIP. As expected, interaction of Ski-DR1 probe with the nuclear extract of fibroblasts yielded a DNA/protein band of mobility (Fig. 3D) . This binding was sequence specific because no protein-DNA complex was observed between the nuclear extract and a mutated or cold Ski-DR1 probe, or in the presence of Ski-DR1 probe but without nuclear extract (Fig. 3D) . Addition of antibody against PPARδ to the reaction mixture resulted in further retarded migration of the radio labeled band (Fig. 3C) , which confirmed the identity of the protein that interacts with the DNA as being PPARδ. And ChIP assay showed that in Fig. 2 . PPARδ induces the transcriptional activity of rat Ski gene promoter. Rat Ski gene promoter region (-2277~-19) was cloned into pGL3-basic vector plasmid and transfected into rat skin fibroblasts. The cells were treated with GW501516 (50 nmol/L) or DMSO with or without pre-treatment of GSK0660, PPARδ antagonist. The reporter assay was performed at least 3 times in triplicate. The luciferase activity was normalized against β-galactosidase activity. Data were mean ± SD and represented as fold induction. *P < 0.05 between the two groups. the samples treated with GW501516, PPARδ was found associated with the PCR-amplified region corresponding to the promoter region containing the putative Ski-DR1 site, whereas no reactivity was detected in the presence of IgG or without treatment with anti-PPARδ antibody (Fig. 3E) . These results further confirm the direct and specific binding of PPARδ to the PPRE (DR1) identified in the Ski promoter region.
PPARδ activation-induced proliferation of fibroblasts largely depends on Ski
Fibroblast proliferation is known to be one essential factor involved in skin wound healing. Accordingly, we examined whether or not PPARδ-regulated Ski expression affects the proliferation of fibroblast. Consistent with our previous report [11] , Ski expression was successfully knockdown by pSuper-Ski-RNAi transfection in fibroblasts (Fig. 4A) . And as shown in Figure 4B , GW501516 markedly accelerate the growth of fibroblast during the detected 72 hours. However, when the cells were pretreated with Ski RNAi the effect of GW501516 was significantly attenuated. This result indicates that Ski is a potential novel 
PPARδ induces Ski expression in vivo and promote rat skin wound healing in a Skidependent manner
Finally, to investigate whether PPARδ can modulate Ski expression in vivo and whether this modulation is implicated in skin wound repair, we examined the level of Ski mRNA and protein in wounds treated with vehicle (DMSO) or GW501516 and observed the associated wound closure and re-epithelialisation in rat skin wound healing model. The results showed that the endogenous Ski mRNA and protein levels increased significantly at 6 days postwounding but decreased at 12 days and 18 days post-wounding in a time dependent manner. However, GW501516 administration could stimulate Ski expression in wounds at both mRNA level (Fig. 5A ) and protein level (Fig. 5B) , which was accompanied with promotion of the skin wound closure (Fig. 5C ). Further histology analysis demonstrated that GW501516 treatment accelerated re-epithelialisation and granulation tissue generation (Fig. 5D ). When compared with the DMSO treatment side, at 6 days post-wounding, the granulation tissue of GW501516-treated side proliferated significantly, with approximately covering the entire wound area by 12 days. In addition, creeping of the epithelium toward the centre of the wound was more rapid after administration of GW501516. On Day 18 post-wounding, continuous intact epithelialization and neoformative granulation tissue were observed in GW501516-treated side to closure the wounding while DMSO-treated side still presented defective epithelialization and unclosed wounding.
Being our recent study has verified pSuper-c-Ski-RNAi injection could successfully knockdown Ski expression in wound, accordingly, in the present study, we used this Ski RNAi to investigate whether GW501516-activated PPARδ activity was associated with regulation of Ski by PPARδ. As expected, the beneficial effects of GW501516 on wound healing were found to be largely blocked when Ski expression was previously interfered (Fig. 5C and D) . Therefore, these results confirm the induction of Ski expression by PPARδ in vivo and suggest that PPARδ promote rat skin wound healing in a Ski-dependent manner. 
Discussion
Nuclear receptor PPARδ has been reported to regulate the expression of multiple genes to elicit a wide spectrum of responses under different physiological and pathological conditions [30, 31] . In skin trauma, activation of PPARδ is found to efficiently promote wound healing [32] [33] [34] [35] , but very little is known about the actual effector genes that it regulates during this course. Here, we demonstrate that PPARδ activation by its specific agonist GW501516 induces the expressions of Ski mRNA and protein in rat fibroblasts. Transfection experiments reveal that Ski expression is regulated by PPARδ at the transcriptional level. Mutation of the DR1 site located in the Ski promoter region abolishes the PPARδ-induced Ski transcription, indicating that this site is a novel type of PPRE. Furthermore, along with upregulation of Ski, activation of PPARδ stimulates the proliferation of fibroblasts in vitro and accelerates wound healing of rat in vivo, which suggests that these effects of PPARδ in wound healing is largely mediated by its target gene Ski. Skin wound repair is divided into three phases: inflammation, epithelialization and remodeling [36] . Keratinocytes, macrophages and dermal fibroblasts is critical for this repair process [37] [38] [39] . Previous studies have demonstrated that activation of PPARδ in keratinocytes increased resistance of the keratinocytes to the apoptotic signals released during wounding, allowing faster re-epithelialisation [23, 35] , and activation of PPARδ in infiltrated macrophages attenuates the inflammatory response [31, 34, 40] , which also promotes repair. In the present study, we found PPARδ is also expressed in rat fibroblasts and its activation siginificantly accelerates the proliferation of fibroblasts along with upregulating the expression of Ski, another wound repair gene. This induction of Ski by PPARδ occurs at the transcriptional level via binding of the PPARδ to the PPRE located in the 5'-flanking region of the Ski gene. Although several potential PPRE are indicated by bioinformatics analysis, we identified DR1 as a cis-element in the promoter region of the Ski gene and demonstrated that it is responsible for PPARδ-induced upregulation of Ski. This DR1 sequence is "AGGTAAGGGGACA", containing a canonical DR1 motif separated by a guanine, which located at -865~-853 of rat Ski gene. The other three putative DR1 sites located at -1264~-1252, -816~-804 or -377~-365 respectively are verified to be not involved in the PPARδ binding and induction.
During the progression of skin wound repair, fibroblasts proliferate and invade lesions, modulate local inflammation, generate ECM to serve as a scaffold for other cells and possess cytoskeletal elements that facilitate contractions of healing wounds. Disorder of fibroblast proliferation would result in delayed wound healing. Our further investigation demonstrates that this binding of PPARδ to Ski promoter is a functional activity which upregulates Ski expression to be responsible for PPARδ-induced fibroblasts proliferation in vitro and rat skin wound healing in vivo. And it provides evidence for the transcriptional regulation of the Ski gene in mammalian cells.
Ski is a co-repressor for transforming growth factor-β (TGF-β)/Smad signaling [5] and TGF-β has been reported to play a dual role influencing tissue repair [41] [42] [43] [44] . Our previous study indicated the essential role for Ski in mediating TGF-β1-induced bi-directional effects on skin fibroblast proliferation through a feedback loop. Kim et al. found TGF-β1 is a molecular target for PPARδ in vascular smooth muscle cells [45] while Tan et al. demonstrated that a cross-talk between TGF-β and PPARδ signaling in wound healing [46] . Hererin, although we have not investigated whether TGF-β expression or activity is affected by the PPARδ-upregulated, on the basis of these findings and references, it might turn out that the interaction of PPARδ, TGF-β and Ski assumes to be closely correlated to maintaining the homeostasis and dictating the outcome of wound tissues.
In addition, it should be noted that Ski is also found to be an oncogene involved in the progression of some carcinomas such as esophageal squamous cell carcinoma, melanoma and lung cancer [47] [48] [49] and PPARδ is reported to either accelerate or suppress tumor growth [50] [51] [52] . Since wound healing closely resembles the phenotypic events that are observed during squamous cell carcinoma progression in many aspects [21] , the cell and tissue specificity of the PPARδ regulation on Ski needs to be detected. Furthermore, the safety and potential paradoxical effects of the application of exogenous PPARδ agonist targeting Ski at wound sites should also be determined to avoid potential side effect of tumorigenesis in further investigation.
In summary, our findings in the present study indicate that Ski is a target gene for PPARδ, which to some extent mediates PPARδ effect on skin wound healing. This has important implications not only for the understanding of the molecular mechanisms underlying the roles of PPARδ in wound repair but also for the transcriptional regulation of the Ski gene. It also provides essential novel evidence to suggest that PPARδ ligands may be used to effect transient activation of local Ski signaling and thus become a therapeutically relevant strategy for the treatment of skin wound. 
